Clinical Trials Sponsored by Boehringer Ingelheim
Total 2533 results
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Laval UniversityMcGill University; Boehringer IngelheimCompletedChronic Obstructive Pulmonary DiseaseCanada
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedMajor Depressive DisorderUnited States, France, Mexico, Puerto Rico
-
Eli Lilly and CompanyBoehringer IngelheimCompletedFibromyalgiaUnited States, Puerto Rico
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHead and Neck CancerUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedAnxiety DisordersUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedAnxiety DisordersUnited States, Finland, France, Germany, South Africa, Spain, Sweden
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Incontinence, StressBrazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Incontinence StressUnited Kingdom
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompletedStress Urinary IncontinenceUnited States
-
University of British ColumbiaBoehringer IngelheimRecruitingIdiopathic Pulmonary FibrosisCanada
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyActive, not recruiting
-
Boehringer IngelheimChina-Japan Friendship HospitalWithdrawn
-
University Health Network, TorontoBoehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Hoosier Cancer Research NetworkBoehringer IngelheimTerminated
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Charite University, Berlin, GermanyBoehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Translational Research in OncologyBoehringer IngelheimTerminatedBreast NeoplasmsUnited States, Spain, Bosnia and Herzegovina, Romania
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Spain, Taiwan, United Kingdom, Czechia, Bulgaria, Israel, Canada, Germany, Malaysia, Argentina, Hungary, Russian Federation, Poland, Ukraine, Korea, Republic of, Croatia, Japan, Netherlands, Portugal, South Africa, ... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, Spain, Taiwan, Belgium, United Kingdom, Germany, Canada, Australia, Finland, Netherlands, Poland, France, Denmark, Norway, Sweden, Austria, Czechia
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Vanderbilt University Medical CenterBoehringer IngelheimCompletedAtrial Fibrillation | Atrial FlutterUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States, Canada, Czech Republic, Denmark, Estonia, Finland, France, Germany, Lebanon, Netherlands, Norway, Sweden
-
Boehringer IngelheimEli Lilly and CompanyCompletedHyperglycemia | Diabetes Mellitus, Type 2United States, Brazil, Canada, Czech Republic, Egypt, France, Germany, Guatemala, Korea, Republic of, Lebanon, Malaysia, Mexico, Peru, Philippines, Russian Federation, Serbia, Spain, Taiwan, Thailand, Turkey, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 1Japan, United States, Greece, Belgium, Poland, Germany, Hungary, Mexico, Romania
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, China, France, Germany, India, Korea, Republic of, Mexico, Slovakia, Slovenia, Taiwan, Turkey
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan